Advertisement
Home Tags Anaphylactic Shock

Tag: Anaphylactic Shock

ASH: Daratumumab + Pomalidomide

2.5 Anaphylaxis Cases Reported Per Million COVID-19 Moderna Vaccine Shots

0

Nine of the 10 cases occurred in individuals with documented history of allergies, allergic reactions

ASH: Daratumumab + Pomalidomide

Allergists Affirm Safety of COVID-19 Vaccines for Most

0

All patients should be observed for 15 minutes after vaccination; staff should be trained in anaphylaxis management

Could the TB Vaccine Help Prevent COVID-19?

11.1 Anaphylaxis Cases/Million Doses of Pfizer-BioNTech COVID-19 Vaccine Reported

0

Median interval from vaccine receipt to symptom onset was 13 minutes

ASH: Daratumumab + Pomalidomide

ACAAI: Reaction to COVID-19 Vaccine Unlikely for Those With Common Allergies

0

Pfizer COVID-19 vaccine should not be administered to individuals with a known history of severe reaction to polyethylene glycol

Among Canadian children

Peanut-, Tree Nut-Induced Anaphylaxis Up on Halloween, Easter

0
Increases in risk for anaphylaxis induced by unknown nuts, peanuts among Canadian children
Certain types of EpiPens and their generic counterparts may fail or delay injection of lifesaving epinephrine for severe allergic reactions

FDA Warns of Defective EpiPen Dangers

0
Devices may activate prematurely if the blue safety release is removed using sideways force
Administering antihistamine medication to a child experiencing anaphylaxis is associated with increased odds of a delay in seeking medical care

AAP: Antihistamine Use for Anaphylaxis May Delay Care Seeking

0
Odds of delay seeking medical care up with administration of antihistamines to child with anaphylaxis
Potential anaphylactic or anaphylactoid reactions have been associated with insertion of peripherally inserted central catheters using the Sherlock tip locating system

Anaphylactic Reactions Tied to PICC Insertion With Magnetic Tip

0
Anaphylactic, anaphylactoid reactions linked to PICC insertion using Sherlock tip locating system
The expiration dates of certain batches of EpiPens have been extended by the U.S. Food and Drug Administration in an effort to reduce shortages of the life-saving devices.

FDA Extends EpiPen Expiration Dates to Tackle Shortage

0
Shortages due to factors such as supply disruptions and manufacturer issues
The first generic version of the EpiPen has been approved by the U.S. Food and Drug Administration

FDA Approves First Generic EpiPen

0
Approval will address both rising costs and shortages of epinephrine